Navigation Links
Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers
Date:6/1/2009

ical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains forward-looking statements, including, but not limited to, statements related to the potential efficacy and therapeutic uses of R788, Rigel's plans to pursue clinical development of R788, and the timing of results thereof. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "may" "believes," "expects" and similar expressions are intended to identify these forward-looking statements. These forward-looking statements are based on the company's current expectations
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Advancements in Integrative Medicine Research to Be Evaluated by Scientists From Leading International Academic Health Centers
2. MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
3. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
4. Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
5. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
6. The National Association of Boards of Pharmacy (NABP) Moves to Next Phase of Technician Recognition and Regulation
7. MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
8. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
9. National Medical Interpreter Certification Testing Enters Pilot Phase
10. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
11. Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... ... vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced their collegiate division, Wimbledon ... previously undiagnosed cardiovascular abnormalities one program at a time. , “Wimbledon ...
(Date:8/4/2015)... ... , ... An article published July 27th by the Providence Journal ... encouraging people to lose weight. Specifically the study compared control patients with those who ... a financial incentive to the overall incentive of increased health. According to Michael Feiz, ...
(Date:8/4/2015)... TX (PRWEB) , ... August 04, 2015 , ... Bayco ... factor small enough to fit, for example, on hard hats that have a flip-up ... Dual-Light Headlamp allows users to work without having to remove their headlamp when ...
(Date:8/4/2015)... ... 04, 2015 , ... It’s hard to look your best, ... in Santa Barbara, CA is offering the solution by offering an underarm sweat-removing ... and odor glands in the underarms. This simple and permanent solution usually offers ...
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power Products acquires ... expanding its reach in Texas. Effective July 1st of this year, Worldwide Power ... division. With the North Texas acquisition, Worldwide Power Products (“WPP”) now services ...
Breaking Medicine News(10 mins):Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:North Texas Acquisition Press Release 2
... 23 Medical device industry,leaders, lawmakers, and government ... the Medical Device Manufacturers Association (MDMA) on,June 12th ... in Washington, D.C., (Logo: http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO ... entrepreneurial medical technology,companies. The Annual Meeting brings leading ...
... Supporting,1500 New Students in Accelerated Nursing Programs, ... (RWJF) and the American Association of Colleges of ... New Careers in Nursing,Scholarship Program, designed to alleviate ... of students in accelerated nursing,programs. Scholarships in the ...
... West Coast Bank,has committed $5,000 to the Children,s ... Courage Event series and other projects,throughout the year., ... and Vice President,said, "It is such a pleasure ... to serving local communities. The Children,s Cancer,Association sponsorship ...
... following Webcast:, What: Heska Corporation Invites You to Listen to ... on the Web, When: Tuesday, May 6, @ 9:00 a.m. (MDT], ... Stockholders link on the front page of ... on to the web at the ...
... Endocrine Society,s 90th Annual MeetingENDO 08will be held at ... 15-18, 2008. , Reporters can register here: ... all over the world are expected to assemble for ... endocrinology. , It is the opportunity for journalists ...
... Americans and certain ethnic groups will have greater effects ... to the latest issue of Public Policy & ... generation and residents of Hispanic and Asian backgrounds will ... The entire issue is authored by cutting-edge demographer William ...
Cached Medicine News:Health News:Key Industry and Government Officials to Address Medical Technology Executives 2Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 2Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 3Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 4Health News:Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast 2Health News:ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more 2
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 ... ) has announced the addition of the ... Patient Comfort and Operational Efficiency, with Growth Driven ... "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" discusses the market, ...
(Date:8/4/2015)... Pittsburgh Life Sciences Greenhouse (PLSG), the region,s only pure ... its portfolio companies, Medrobotics Corporation, has received FDA market ... in the U.S.  "I couldn,t be ... John W. Manzetti , president and CEO of PLSG. ... out of The Robotics Institute at Carnegie Mellon University ...
(Date:8/4/2015)... N.J. , Aug. 4, 2015 /PRNewswire/ ... University of Massachusetts Medical School,s Clinical Pharmacy ... support regarding clinical protocols and therapy interventions ... Specialty medication therapy management ... helps to ensure optimal patient outcomes are ...
Breaking Medicine Technology:Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 2Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 3
... Utilizing the most complex grinding ... accurate trial lens, are specifically ... quality and precision as the ... marco RT-300 refractor. Marco custom ...
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
Minus cylinders only trial lens set....
Medicine Products: